Skip to main content

Table 3 Basic characteristics of participants in stage-2 study

From: Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease

 

HC

NA

MA

OA

Number

20

20

20

20

Age

49.7 ± 7.5

50.6 ± 15.3

50.1 ± 13.7

55.7 ± 14.0

Gender (male/female)

13/7

11/9

13/7

14/6

eGFR (ml/min/1.73 m2)

102.6 [95.0–114.6]

102.6 [77.1–115.0]

88.5 [79.2–138.8]

82.9 [32.8–123.8]*

ACR (mg/g)

10.1 [4.7–15.1]

12.0 [5.9–20.5]

78.4 [58.8–149.3]*

1503.0 [619.9–3743.0]*

Glu (mmol/L)

4.9 [4.3–5.2]

8.6 [7.0–11.1]*

10.1 [7.5–12.7]*

12.3 [7.5–15.0]*

HbA1c (%)

4.9 [4.7–5.2]

8.3 [7.0–10.2]*

8.5 [6.8–9.3]*

9.1 [8.2–11.1]*

SBP (mmHg)

116.5 ± 9.5

123.2 ± 10.6

135.4 ± 12.3*

145.5 ± 18.6*

DBP (mmHg)

74.3 ± 5.8

80.2 ± 7.3

82.5 ± 10.1*

85.5 ± 7.8*

Urinary NAG/Cr (U/mol)

0.48 ± 0.14

0.69 ± 0.27

1.17 ± 0.44*

1.93 ± 0.53*

  1. p < 0.05 compared with HCs